Skip to main content
. 2015 Jun;11(2):54–60.

Table 1.

SF-36 scores at baseline

Dimension SF-36 ( X ± S )
t P
Mega MSM (n=49) Placebo (n=50)

PF 54.59 ± 23.71 61.00 ± 18.98 -1.486 0.141
RP 32.65 ± 45.13 49.50 ± 49.36 -1.773* 0.079
BP 60.61 ± 13.76 64.40 ± 14.02 -1.357 0.178
GH 58.16 ± 23.38 56.40 ± 18.55 0.416 0.678
VT 72.96 ± 18.28 69.90 ± 15.89 0.889 0.376
SF 67.09 ± 22.63 72.00 ± 18.48 -1.183 0.240
RE 97.28 ± 14.96 89.33 ± 28.92 1.722a 0.089
MH 83.76 ± 8.92 74.00 ± 15.36 3.842a 0.000
HT 43.88 ± 13.04 44.00 ± 11.91 -0.049 0.961
PCS 206.02 ± 88.13 231.30 ± 86.05 -1.444 0.152
MCS 321.09 ± 46.71 305.31 ± 51.52 1.595 0.114
Total score 570.98 ± 132.73 580.61 ± 131.96 -0.362 0.718
a

t’ test.